Clinical chemotherapeutic agent coordinated copper-elesclomol nanomedicine potentiates cuproptosis for high-efficiency chemo-immunotherapy of prostate cancer

Journal of Materials Science 2026

View at publisher

Authors: Ming Liu, Xianzhou Jiang, Bing Zhang, Zehua Wang, Yanhui Zhang

DOI: 10.1007/s10853-026-12190-4

Cited by: 0

References: 37

Fields of Study & Subjects

Nanoplatforms for cancer theranostics Nanoparticle-Based Drug Delivery Ferroptosis and cancer prognosis

References 37